Debra BorchardtJanuary 4, 2024
Beckley Psytech focuses on short duration psychedelic drug treatments.
Tag: psychedelics
Debra BorchardtJanuary 4, 2024Debra BorchardtDecember 14, 2023
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) announced positive topline results from its Phase 2b clinical trial of MM-120 (lysergide d-tartrate) in generalized anxiety disorder (GAD). MindMed said that its trial met its primary endpoint, with MM-120 demonstrating statistically significant and clinically meaningful dose-dependent improvements on the Hamilton Anxiety rating scale (HAM-A) compared to […]
Debra BorchardtDecember 14, 2023
A Seattle doctor is not giving up when it comes to the rescheduling of psilocybin. While the focus on rescheduling cannabis is talked about constantly, psilocybin also faces the same dilemma of being a schedule one drug. Law360 reported that Seattle physician Dr. Sunil Aggarwal filed a petition on Dec. 11, nearly two months after […]
Debra BorchardtDecember 11, 2023
The author suggests synthetic psychedelics may have a better chance for federal legalization.
Debra BorchardtDecember 11, 2023
The company is targeting a listing on the Australian Securities Exchange.
StaffDecember 6, 2023
The Daily Hit is a recap of the top financial news stories for Dec. 6, 2023. On the Site Parallel Stockholders Reject Proposed Restructuring in Billion-Dollar Lawsuit A group of 40 disgruntled Parallel cannabis stockholders filed a lawsuit in the Chancery Court of Delaware rejecting the proposed restructuring of the debt-ridden cannabis company. Read more […]
John SchroyerNovember 1, 2023
To facilitate the acquisition, Beckley founded a new subsidiary, NueCo Holdings PBC.
Debra BorchardtOctober 17, 2023
The $16 million gift will include an endowed professorship with a broad focus on human health and flourishing.
Debra BorchardtOctober 10, 2023
California Governor Gavin Newsom vetoed Senate Bill 58 which would have decriminalized several plant-based psychedelic drugs. The state has long been a leader in easing various drug laws beginning with cannabis, but the Governor just said no to this piece of legislation. Governor Newsom also issued a letter stating that he wasn’t opposed to the […]
Debra BorchardtSeptember 19, 2023Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), closed its United States-only public offering raising approximately $2.25 million. The offering consisted of 7,500,000 common shares and pre-funded warrants and 7,500,000 common warrants. Clearmind said it plans to use the money for general corporate purposes, which may include operating expenses, research, and development, including clinical and pre-clinical […]
Get the latest cannabis news delivered right to your inbox
Unpack the industry with the daily cannabis newsletter for business leaders.